Latest Period
Q2 2026
Security Snapshot
Cogent Biosciences, Inc. - Common Stock (COGT) Institutional Ownership
CUSIP: 19240Q201
13F Institutional Holders and Ownership History from Q4 2020 to Q2 2026
Institutions Reporting
318
Shares (Excl. Options)
193,603,274
Price
$38.70
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- COGT on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 193,603,274
- Total 13F value
- $7,492,605,534
- Portfolio coverage rank
- 0.01%
- Share change
- +6,732,723
- Value change
- +$261,452,882
- Number of holders
- 318
- Shares outstanding
- 173,823,056
- SEC-reported price per share
- $41.36
- Insider filing price
- $41.36
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- COGT - Cogent Biosciences, Inc. - Common Stock is tracked under CUSIP 19240Q201.
- 318 institutions reported positions in Q2 2026.
- 11 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 304 to 318 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $7,169,929,269 to $7,492,605,534.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 318 institutions filings for Q2 2026.
Security key
19240Q201
Latest holder period
Q2 2026
13F holders
318
13D/G owners
11
CIK / CUSIP context first
Open Q2 2026 holders
COGT full holder history
Cogent Biosciences, Inc. SEC filings
Cogent Biosciences, Inc. company facts
Cogent Biosciences, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 19240Q201:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
11
Security
COGT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 15% | $81,355,047 | 16,569,256 | FMR LLC | 31 Dec 2024 | |||
| Fairmount Funds Management LLC | 8.6% | -13% | $542,559,913 | -$31,973,650 | 15,356,918 | -5.6% | Fairmount Funds Management LLC | 31 Mar 2026 |
| BlackRock, Inc. | 8% | +21% | $526,051,538 | +$86,023,869 | 13,593,063 | +20% | BlackRock, Inc. | 30 Jun 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.1% | $336,364,494 | 8,691,589 | Vanguard Capital Management | 30 Jun 2026 | |||
| TCG Crossover GP I, LLC | 4.8% | $97,621,606 | 6,798,162 | TCG Crossover GP I, LLC | 30 Sep 2025 | |||
| Kynam Capital Management, LP | 4.3% | -20% | $219,296,982 | -$61,214,156 | 6,165,223 | -22% | Kynam Capital Management, LP | 31 Dec 2025 |
| Point72 Asset Management, L.P. | 4% | -52% | $82,625,042 | -$60,775,814 | 5,753,833 | -42% | Point72 Asset Management, L.P. | 30 Sep 2025 |
| Flynn James E | 2.9% | -48% | $193,736,225 | -$156,262,821 | 5,006,104 | -45% | Deerfield Mgmt, L.P. | 30 Jun 2026 |
| Venrock Healthcare Capital Partners II, L.P. | 4.2% | -27% | $44,463,093 | -$15,815,581 | 4,755,411 | -26% | Venrock Healthcare Capital Partners II, L.P. | 30 Jun 2025 |
| Paradigm Biocapital Advisors LP | 2.3% | -76% | $45,325,875 | -$103,335,292 | 3,156,398 | -70% | Paradigm BioCapital Advisors LP | 30 Sep 2025 |
| Commodore Capital LP | 1.8% | -77% | $99,699,331 | -$263,401,363 | 2,802,905 | -73% | Commodore Capital LP | 31 Dec 2025 |
As of 30 Jun 2026, 318 institutional investors reported holding 193,603,274 shares of Cogent Biosciences, Inc. - Common Stock (COGT). This represents 111% of the company’s total 173,823,056 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
78%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 15% | 25,681,174 | +11% | 0.04% | $993,861,419 |
| BlackRock, Inc. | 10% | 17,352,646 | +8.1% | 0.01% | $671,547,401 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.6% | 8,072,411 | +10% | 0.01% | $312,402,306 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.3% | 7,412,330 | +7.5% | 0.01% | $286,857,171 |
| STATE STREET CORP | 4% | 6,964,919 | +23% | 0.01% | $269,542,365 |
| Jupiter Topco LLC | 3.8% | 6,624,848 | 0% | 0.1% | $256,422,695 |
| Fairmount Funds Management LLC | 3.2% | 5,503,418 | 0% | 14% | $212,982,277 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2.9% | 5,006,104 | -45% | 2% | $193,736,225 |
| TCG Crossover Management, LLC | 2.8% | 4,854,436 | -1.9% | 4.5% | $187,866,673 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.7% | 4,652,727 | +45% | 0.02% | $180,062,000 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.6% | 4,508,998 | +22% | 0.01% | $174,534,880 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.5% | 4,343,977 | +21% | 0.03% | $168,111,910 |
| Kynam Capital Management, LP | 2.1% | 3,667,097 | -9.2% | 7.8% | $141,916,654 |
| LORD, ABBETT & CO. LLC | 2% | 3,431,030 | +7.9% | 0.38% | $132,781,000 |
| Polar Capital Holdings Plc | 1.9% | 3,232,905 | 0.35% | $125,113,424 | |
| Commodore Capital LP | 1.8% | 3,050,000 | +5.6% | 7% | $118,035,000 |
| Invesco Ltd. | 1.5% | 2,609,141 | +7.4% | 0.01% | $100,973,759 |
| Woodline Partners LP | 1.5% | 2,603,162 | +72% | 0.31% | $100,742,369 |
| Pictet Asset Management Holding SA | 1.4% | 2,393,515 | +33% | 0.09% | $92,634,023 |
| Octagon Capital Advisors LP | 1.4% | 2,350,000 | 0% | 8.3% | $90,945,000 |
| RTW INVESTMENTS, LP | 1.3% | 2,309,021 | -58% | 0.76% | $89,359,113 |
| GOLDMAN SACHS GROUP INC | 1.3% | 2,288,633 | -48% | 0.01% | $88,570,098 |
| Candriam S.C.A. | 1.2% | 2,088,369 | +38% | 0.36% | $80,742,121 |
| Deep Track Capital, LP | 1.2% | 2,000,000 | +100% | 1.1% | $77,400,000 |
| Siren, L.L.C. | 1.1% | 1,859,279 | +8.8% | 1.5% | $71,954,097 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
23
Latest
Q2 2026
Rows shown
1-23 of 23
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 193,603,274 | $7,492,605,534 | +$261,452,882 | $38.70 | 318 |
| 2026 Q1 | 186,329,242 | $7,169,929,269 | +$317,721,394 | $38.49 | 304 |
| 2025 Q4 | 174,084,958 | $6,184,105,170 | +$561,964,697 | $35.52 | 266 |
| 2025 Q3 | 159,224,831 | $2,286,403,568 | +$377,675,482 | $14.36 | 192 |
| 2025 Q2 | 135,519,487 | $973,045,860 | +$18,987,122 | $7.18 | 175 |
| 2025 Q1 | 133,492,788 | $799,614,961 | +$57,857,622 | $5.99 | 182 |
| 2024 Q4 | 121,716,056 | $949,488,255 | -$21,661,319 | $7.80 | 173 |
| 2024 Q3 | 121,834,182 | $1,316,352,629 | +$470,587 | $10.80 | 160 |
| 2024 Q2 | 121,381,737 | $1,023,259,146 | +$106,597,224 | $8.43 | 146 |
| 2024 Q1 | 109,208,822 | $733,878,161 | +$128,257,287 | $6.72 | 144 |
| 2023 Q4 | 90,814,821 | $533,992,647 | -$45,403,172 | $5.88 | 141 |
| 2023 Q3 | 90,861,393 | $885,844,189 | +$20,538,646 | $9.75 | 134 |
| 2023 Q2 | 88,529,694 | $1,048,151,896 | +$158,614,636 | $11.84 | 134 |
| 2023 Q1 | 75,176,767 | $810,346,243 | +$3,226,883 | $10.79 | 133 |
| 2022 Q4 | 74,675,712 | $863,268,307 | -$1,804,375 | $11.56 | 133 |
| 2022 Q3 | 73,734,143 | $1,100,096,408 | +$70,755,840 | $14.92 | 129 |
| 2022 Q2 | 70,081,829 | $632,136,824 | +$209,072,563 | $9.02 | 107 |
| 2022 Q1 | 47,217,562 | $353,580,440 | -$5,659,624 | $7.49 | 81 |
| 2021 Q4 | 44,899,168 | $385,164,997 | +$41,807,073 | $8.58 | 80 |
| 2021 Q3 | 36,797,124 | $309,606,147 | +$4,142,169 | $8.41 | 71 |
| 2021 Q2 | 34,971,040 | $283,623,000 | +$12,872,399 | $8.11 | 65 |
| 2021 Q1 | 34,431,767 | $303,253,000 | +$9,820,126 | $8.78 | 65 |
| 2020 Q4 | 33,524,756 | $376,481,000 | +$318,450,000 | $11.23 | 67 |